20 - 22 February, 2012, Guoman Charing Cross, London, UK
LAST PLACES AVAILABLE – REGISTER TODAY!
Download the Brochure
Click here to access Download Centre
Become a Pharma IQ Member and receive our weekly newsletter!
Connect to a global Pharma IQ social network
Linkedin
Twitter
Facebook
Learn more about sponsor & exhibit opportunities
Mark Your Calendar
Tell a Colleague
Chair:
Julian Morris Technical Director Centre for Process Analytics and Control Technology
Gawayne Mahboubian - Jones Program Manager QbD Phillip Morris International
Nuno Matos PAT specialist Hovione
Tom Cochrane Business Process Development Manager Napp Pharmaceutical Group
1. Realising the Financial Benefits of PAT and QbD and How to Reduce Business Risk
Facilitator:
2. Assessing the Guidelines for Risk Management
Gawayne Mahboubian Jones Program Manager QbD Phillip Morris International
3. The Application of PAT and QbD for Biopharmaceuticals
Ali Afnan President Step Change Pharma
Mel Koch Marketing Director Centre for Process Analysis and Control
This session is reserved for a leading provider of PAT and QbD Technology, if you think your product would be of interest to the delegation, get in touch on +44 207 368 9300 or email sponsorship@iqpc.co.uk
Mette Kraemmer Hansen Quality Expert and Quality Management Specialist Novo Nordisk
Marie Calame Pharmaceutical Engineering Technical Manager Sanofi Aventis
[ Register Now ]